SARS-CoV-2 Variants, South Sudan, January-March 2021.
COVID-19
SARS-CoV-2
South Sudan
coronavirus disease
respiratory infections
severe acute respiratory syndrome coronavirus 2
variants
viruses
zoonoses
Journal
Emerging infectious diseases
ISSN: 1080-6059
Titre abrégé: Emerg Infect Dis
Pays: United States
ID NLM: 9508155
Informations de publication
Date de publication:
12 2021
12 2021
Historique:
pubmed:
29
10
2021
medline:
25
11
2021
entrez:
28
10
2021
Statut:
ppublish
Résumé
As the coronavirus pandemic continues, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) sequence data are required to inform vaccine efforts. We provide SARS-CoV-2 sequence data from South Sudan and document the dominance of SARS-CoV-2 lineage B.1.525 (Eta variant) during the country's second wave of infection.
Identifiants
pubmed: 34708685
doi: 10.3201/eid2712.211488
pmc: PMC8632182
doi:
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
3133-3136Subventions
Organisme : Wellcome Trust
Pays : United Kingdom
Organisme : Medical Research Council
ID : MC_EX_MR/L016273/1
Pays : United Kingdom
Références
Nat Microbiol. 2021 Aug;6(8):1094-1101
pubmed: 34163035
Emerg Infect Dis. 2021 Jun;27(6):1598-1606
pubmed: 34013872
Mol Cell. 2020 May 21;78(4):779-784.e5
pubmed: 32362314
Nature. 2021 Mar;591(7849):293-299
pubmed: 33494095
Virus Evol. 2021 Feb 04;7(1):veab006
pubmed: 33841912
Mol Biol Evol. 2020 Jan 1;37(1):291-294
pubmed: 31432070
Bioinformatics. 2019 Nov 1;35(21):4453-4455
pubmed: 31070718